Arkolith/Insider Trading/GMED/Form 4

Scavilla Daniel T

President, CEO, DirectorGLOBUS MEDICAL INC (GMED) · full profile →Form 4 · filed Nov 25, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$11.1M
Net Open-Market Flow
-$11.1M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 21, 2024Option exercise(M)50K$43.77$2.2M50K
Nov 21, 2024Option exercise(M)80K$43.58$3.5M130K
Nov 21, 2024Sell(S)130K$85.00$11.1M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 21, 2024Option exercise(M)50K—$00
Nov 21, 2024Option exercise(M)80K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-130588) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML